Abstract
Skeletal muscle insulin resistance has been linked to mitochondrial dysfunction. We examined how improvements in muscular insulin sensitivity following rosiglitazone (ROSI) or pioglitazone (PIO) treatment would affect muscle mitochondrial function in patients with type 2 diabetes mellitus (T2DM).
| Original language | English |
|---|---|
| Journal | Diabetic Medicine |
| Volume | 12 |
| Issue number | 9 |
| Pages (from-to) | 806-14 |
| Number of pages | 8 |
| ISSN | 0742-3071 |
| DOIs | |
| Publication status | Published - 2010 |
Keywords
- Body Mass Index
- Cell Respiration
- Diabetes Mellitus, Type 2
- Female
- Hemoglobin A, Glycosylated
- Humans
- Hypoglycemic Agents
- Immunohistochemistry
- Insulin Resistance
- Male
- Middle Aged
- Mitochondria, Muscle
- Muscle, Skeletal
- Thiazolidinediones
Fingerprint
Dive into the research topics of 'Opposite effects of pioglitazone and rosiglitazone on mitochondrial respiration in skeletal muscle of patients with type 2 diabetes'. Together they form a unique fingerprint.Cite this
- APA
- Standard
- Harvard
- Vancouver
- Author
- BIBTEX
- RIS